(NASDAQ:ROP), SARASOTA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth quarter 2025 highlights Revenue increased 10% to $2.06 billion; acquisition contribution was +5% and organic revenue was +4% GAAP net earnings decreased 7% to $428 million; […]
(NASDAQ:ACRS), – ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype – WAYNE, Pa., Jan. 27, 2026 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced recent positive preclinical results from its potent and selective ITK/JAK3
CHICAGO and MILWAUKEE and NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) — YieldMax(R) ETFs announced distributions for the YieldMax(R) Group 1 weekly pay ETFs. Group 1 Distribution Announcement Ex. & Record Date: January 28, 2026Payment Date: January 29, 2026 ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5 CHPY YieldMax(R)
Roper Technologies announces 2025 financial results Initiates 2026 guidance GlobeNewswire January 27, 2026 SARASOTA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth quarter 2025 highlights Revenue increased 10% to $2.06 billion; acquisition contribution was +5% and
Aclaris Therapeutics' Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA) GlobeNewswire January 27, 2026 – ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype – WAYNE, Pa., Jan. 27, 2026 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
YieldMax(R) ETFs Announces Weekly Distributions for Group 1 ETFs GlobeNewswire January 27, 2026 CHICAGO and MILWAUKEE and NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) — YieldMax(R) ETFs announced distributions for the YieldMax(R) Group 1 weekly pay ETFs. Group 1 Distribution Announcement Ex. & Record Date: January 28, 2026Payment Date: January 29, 2026 ETF Ticker1 ETF
Natural Carotenoids Market Expected to Reach USD 708.03 Million by 2035 Amid Rising Functional Nutrition Trends According to Towards FnB, the global natural carotenoids market size is calculated at USD 497.45 million in 2026 and is expected to reach USD 708.03 million by 2035, registering a CAGR of 4% during the 2026 to 2035 forecast
(NYSE:NOC), FALLS CHURCH, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its fourth quarter and full-year 2025 financial results. A copy of the earnings release has been furnished in the company's Form 8-K filing and is also available on the company's investor relations website at http://investor.northropgrumman.com. Earnings Call Webcast
Northrop Grumman Releases Fourth Quarter and Full-Year 2025 Financial Results GlobeNewswire January 27, 2026 FALLS CHURCH, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its fourth quarter and full-year 2025 financial results. A copy of the earnings release has been furnished in the company's Form 8-K filing and is
The January 2026 edition of BizClik's Sustainability portfolio is now live, featuring fresh insights from Sustainability Magazine. This month's issues spotlight global leaders, breakthrough technologies, and critical sustainability strategies. London – 27 January 2026- BizClik, a global B2B media and events company, has released the latest magazine editions of its Sustainability portfolio, featuring: Sustainability Magazine